LOW-DOSE IL-2 RESTORES TREG-MEDIATED IMMUNE TOLERANCE IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS

被引：1
|
作者：
Wu, R. [1 ]
Su, R. [1 ]
Ding, T. [1 ]
Xue, H. [1 ]
An, J. [1 ]
Jiang, L. [1 ]
Li, X. F. [1 ]
Wang, C. [1 ]
机构：
[1] Shanxi Med Univ, Hosp 2, Taiyuan, Peoples R China
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.4346
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0278
引用
收藏
页码：1079 / 1080
页数：2
相关论文
共 50 条
  • [1] During aGVHD low-dose IL-2 activates allogeneic T cells and fails to induce Treg-mediated tolerance
    Perol, L.
    Martin, G. H.
    Cohen, J. L.
    Piaggio, E.
    IMMUNOLOGY, 2012, 137 : 740 - 740
  • [2] Low-dose rituximab as induction therapy for ANCA-associated vasculitis
    Yukiko Takakuwa
    Hironari Hanaoka
    Tomofumi Kiyokawa
    Harunobu Iida
    Hisae Fujimoto
    Yoshioki Yamasaki
    Hidehiro Yamada
    Kimito Kawahata
    Clinical Rheumatology, 2019, 38 : 1217 - 1223
  • [3] Low-dose rituximab as induction therapy for ANCA-associated vasculitis
    Takakuwa, Yukiko
    Hanaoka, Hironari
    Kiyokawa, Tomofumi
    Iida, Harunobu
    Fujimoto, Hisae
    Yamasaki, Yoshioki
    Yamada, Hidehiro
    Kawahata, Kimito
    CLINICAL RHEUMATOLOGY, 2019, 38 (04) : 1217 - 1223
  • [4] LOW-DOSE RITUXIMAB AS INDUCTION THERAPY FOR JAPANESE PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Takakuwa, Y.
    Hanaoka, H.
    Kiyokawa, T.
    Ishimori, K.
    Iida, H.
    Nagafuchi, H.
    Okazaki, T.
    Ozaki, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1260 - 1260
  • [5] Safety of Methotrexate and Low-Dose Trimethoprim-Sulfamethoxazole in Patients with ANCA-Associated Vasculitis
    Tamaki, Hiromichi
    Butler, Robert
    Langford, Carol A.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [6] Low-Dose Intravenous Methylprednisolone in Remission Induction Therapy for ANCA-Associated Vasculitis
    Floyd, Lauren
    Morris, Adam D.
    Shetty, Anamay
    Brady, Mark E.
    Ponnusamy, Arvind
    Warwicker, Paul
    Dhaygude, Ajay
    KIDNEY360, 2023, 4 (09): : 1286 - 1292
  • [7] Rituximab in ANCA-associated vasculitis: fewer infusions or ultra low-dose maintenance therapy?
    Moiseev, Sergey V.
    Bulanov, Nikolai M.
    Zykova, Anastasiia S.
    Novikov, Pavel I.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (09) : E99 - +
  • [8] IL-21 downregulates T cell IL-2 production and impairs Treg-mediated immune regulation
    Attridge, K.
    Wang, C. J.
    Wardzinski, L.
    Clough, L.
    Kenefeck, R.
    Kopf, M.
    Walker, L. S. K.
    IMMUNOLOGY, 2011, 135 : 124 - 124
  • [9] Overlapping drug-induced vasculitis, ANCA-associated vasculitis, and lupus nephritis caused by low-dose hydralazine
    Bhatnagar, M.
    Agaronov, A.
    Sarkisyan, E.
    Deilamy, I. Sotoudeh
    Pepito, D.
    Akhondi, H.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (11) : 2272 - 2277
  • [10] PLASMAPHERESIS, RITUXIMAB AND LOW-DOSE CYCLOPHOSPHAMIDE FOR REMISSION INDUCTION THERAPY IN SEVERE ANCA-ASSOCIATED VASCULITIS
    Gulati, Kavita
    McAdoo, Stephen
    Galliford, Jack
    Griffith, Megan
    Levy, Jeremy
    Cairns, Tom
    Pusey, Charles
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
12345